Everest Organics Limited (BSE: 524790)
Health Care · Pharmaceuticals · IN
Rs240.65
+9.49% today · -38.5% 1Y
Everest Organics Limited (BSE: 524790) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $24.15M.
Over the last twelve months the share price has lost 38.5%, trading between 197.00 and 536.40.
Tweenvest scores Everest Organics Limited across four factors: quality 55/100, value 57/100, growth 53/100. Its strongest factor is value.
524790 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $24.15M
- Revenue (TTM)
- $20.29M
- P/E
- 44.55
- EPS
- 5.40
- Dividend yield
- —
- Beta (5Y)
- 0.56
- 52-week high
- Rs536.40
- 52-week low
- Rs197.00
- Avg volume (3M)
- —
- Shares outstanding
- 9.71M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| MedRx Co., LtdTSE: 4586 | $25.10M | ¥58.00 | -1.69% |
| Yung Zip Chemical Ind. Co., Ltd.TPEX: 4102 | $24.91M | NT$18.80 | +1.90% |
| iAnthus Capital Holdings, Inc.CNSX: IAN | $24.44M | CA$0.01 | -50.00% |
| Orexo AB (publ)OM: ORX | $24.32M | Skr6.19 | -5.93% |
| Gennex Laboratories LimitedBSE: 531739 | $24.12M | Rs9.61 | -1.94% |
| PT Indofarma TbkIDX: INAF | $23.91M | Rp— | — |
| TherapeuticsMD, Inc.NasdaqGS: TXMD | $23.84M | $2.02 | -1.94% |
| Quantum BioPharma Ltd.NasdaqCM: QNTM | $23.78M | $2.80 | -4.76% |
Figures last refreshed Oct 11, 2026.